The radiologic spectrum of neuroendocrine tumors in emergent care

Zheng Z, Chen C, Jiang L, et al. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: a population-based study. Cancer Med. 2019;8(17):7288–98.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115–54.

Article  PubMed  CAS  Google Scholar 

Yao JC, Hassan M, Phan A, et al. One hundred years after Carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72.

Article  PubMed  Google Scholar 

Lamberti G, La Salvia A. Neuroendocrine tumors: challenges and Future perspectives. J Clin Med. 2022;11(15):4351.

Article  PubMed  PubMed Central  Google Scholar 

Rossi RE, Massironi S. The increasing incidence of neuroendocrine neoplasms worldwide: current knowledge and open issues. J Clin Med. 2022;11(13):3794.

Article  PubMed  PubMed Central  Google Scholar 

Das S, Dasari A, Epidemiology. Incidence, and prevalence of neuroendocrine neoplasms: are there global differences? Curr Oncol Rep. 2021;23(4):43.

Article  PubMed  PubMed Central  Google Scholar 

Simoneaux R. A look at the increasing incidence of neuroendocrine tumors. Oncol Times. 2020;42(6):1–4.

Article  Google Scholar 

Massironi S, Franchina M, Ippolito D, Elisei F, Falco O, Maino C, Invernizzi P. Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms. Expert Rev Endocrinol Metabolism. 2024;19(4):349–66.

Article  CAS  Google Scholar 

Klimstra DS, Klöppel G, La Rosa S, Rindi GW. Classification of neuroendocrine neoplasms of the digestive system. In: Digestive system tumours: WHO classification of tumours, 5th ed., vol. 1. IARC Press; 2019 ( pp. 16–19).

Google Scholar 

La Rosa S, Uccella S. Classification of neuroendocrine neoplasms: lights and shadows. Reviews Endocr Metabolic Disorders. 2021;22(3):527–38.

Article  Google Scholar 

Vinik AI, Chaya C. Clinical presentation and diagnosis of neuroendocrine tumors. Hematol Oncol Clin North Am. 2016;30(1):21–48.

Article  PubMed  Google Scholar 

Esposito I, Klöppel G, Esposito I, Kasajima A, La Rosa S, Dizdar L, Knoefe WT, Schott M, Dromain C, Villard N, Lena H. Neuroendocrine neoplasms of the digestive system. Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach 2e. 2024 Jan 23:470–537.

Rizen EN, Phan AT. Neuroendocrine tumors: a relevant Clinical Update. Curr Oncol Rep. 2022;24(6):703–14.

Article  PubMed  CAS  Google Scholar 

Pirasteh A, Lovrec P, Bodei L. Imaging of neuroendocrine tumors: a pictorial review of the clinical value of different imaging modalities. Rev Endocr Metab Disord. 2021;22(3):539–52.

Article  PubMed  Google Scholar 

Modica R, Benevento E, Liccardi A, Cannavale G, Minotta R, DI Iasi G, Colao A. Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms. Minerva Endocrinol (Torino). 2024;49(2):158–74. https://doi.org/10.23736/S2724-6507.23.04140-4. Epub 2024 Apr 16. PMID: 38625065.

Article  PubMed  Google Scholar 

de Celis Ferrari ACR, Glasberg J, Riechelmann RP. Carcinoid syndrome: an update on the pathophysiology and treatment. Clinics. 2018;73:e490s.

Article  PubMed Central  Google Scholar 

Condron ME, Pommier SJ, Pommier RF. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis. Surgery. 2016;159(1):358–67.

Article  PubMed  Google Scholar 

Al-Toubah T, Strosberg J. Somatostatin Analogs and Interferon in the Treatment of Neuroendocrine Tumors. Neuroendocrine Tumours: Diagnosis and Management. 2024 Sep 3:619– 30.

Caplin ME, Pavel M, Ćwikła JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371(3):224–33.

Article  PubMed  Google Scholar 

Abenavoli E, Linguanti F, Briganti V, et al. carcinogensTypical lung carcinoids: review of classification, radiological signs, and nuclear imaging findings. Clin Transl Imaging. 2020;8(2):79–94.

Article  Google Scholar 

Papaxoinis G, Lamarca A, Quinn AM, Mansoor W, Nonaka D. Clinical and pathologic characteristics of pulmonary carcinoid tumors in central and peripheral locations. Endocr Pathol. 2018;29(3):259–68.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ketai LH, Mohammed TH, Kirsch J, Kanne JP, Chung JH, Donnelly EF, et al. ACR appropriateness criteria hemoptysis. J Thorac Imaging. 2014;29:W19–22.

Article  PubMed  Google Scholar 

Larici AR, Franchi P, Occhipinti M, et al. Diagnosis and management of hemoptysis. Diagn Interv Radiol. 2014;20:299–309. https://doi.org/10.5152/dir.2014.13426.

Article  PubMed  PubMed Central  Google Scholar 

Olsen KM, Manouchehr-Pour S, Donnelly EF, Henry TS, Berry MF, Boiselle PM, Colletti PM, Harrison NE, Kuzniewski CT, Laroia AT, Maldonado F. ACR appropriateness criteria® hemoptysis. J Am Coll Radiol. 2020;17(5):S148–59.

Article  PubMed  Google Scholar 

Hofland J, Kaltsas G, de Herder WW. Advances in the diagnosis and management of well-differentiated neuroendocrine neoplasms. Endocr Rev. 2020;41(2):371–403.

Article  PubMed  PubMed Central  Google Scholar 

Danti G, Berti V, Abenavoli E, et al. Diagnostic imaging of typical lung carcinoids: relationship between MDCT, 111In-Octreoscan and 18F-FDG-PET imaging features with Ki-67 index. Radiol Med. 2020;125(8):715–29.

Article  PubMed  Google Scholar 

Santiago-Naranjo KC, Ilaiwy A. Pulmonary carcinoid presenting with persistent pneumothorax. BMJ Case Rep. 2019;12(11):e231083.

Article  PubMed  PubMed Central  Google Scholar 

Shah M, Duong B, Karnath B, Nishi S, Rasmussen P. Carcinoid Tumor Presenting as Hemoptysis and Elevated Diaphragm. Cureus 2023.

Jahangiri OS, Robbins JR, Nagaraju S. Cureus. Masquerading as Pneumonia: A Lung Neuroendocrine Tumor Case Report. 2023.

Baghdadi A, Ghadimi M, Mirpour S, et al. Imaging neuroendocrine tumors: characterizing the spectrum of radiographic findings. Surg Oncol. 2021;37:101529.

Article  PubMed  Google Scholar 

Nakazono T, Yamaguchi K, Egashira R, Mizuguchi M, Irie H. Anterior mediastinal lesions: CT and MRI features and differential diagnosis. Jpn J Radiol. 2021;39(2):101–17.

Article  PubMed  Google Scholar 

Maxwell JE, Naraev B, Halperin DM, Choti MA, Halfdanarson TR. Shifting paradigms in the pathophysiology and treatment of Carcinoid Crisis. Ann Surg Oncol. 2022;29(5):3072–84.

Article  PubMed  Google Scholar 

Derks JL, Rijnsburger N, Hermans BC, Moonen L, Hillen LM, von der Thüsen JH, den Bakker MA, van Suylen RJ, Speel EJ, Dingemans AM. Clinical-pathologic challenges in the classification of pulmonary neuroendocrine neoplasms and targets on the horizon for future clinical practice. J Thorac Oncol. 2021;16(10):1632–46.

Article  PubMed  CAS  Google Scholar 

Ackman JB, Chung JH, Walker CM, Bang TJ, Carter BW, Hobbs SB, Kandathil A, Lanuti M, Madan R, Moore WH, Shah SD. ACR appropriateness Criteria® imaging of mediastinal masses. J Am Coll Radiol. 2021;18(5):S37–51.

Article  PubMed  Google Scholar 

Phan AT, Öberg K, Choi J, Harrison LH Jr, Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA, Maples WJ. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 2010;39(6):784–98.

Article  PubMed  Google Scholar 

Shikhare SN. Imaging of thoracic malignancies. Thorac Imaging: Basic Adv. 2019;101:46.

Google Scholar 

Cattoni M, Vallières E, Brown LM, et al. Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumors. Eur J Cardiothorac Surg. 2017;51(5):874–9.

Article  PubMed  Google Scholar 

Koukouraki S, Strauss LG, Georgoulias V, Eisenhut M, Haberkorn U, Dimitrakopoulou-Strauss A. Comparison of the pharmacokinetics of 68 Ga-DOTATOC and [18 F] FDG in patients with metastatic neuroendocrine tumours scheduled for 90 Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging. 2006;33:1115–22.

Article  PubMed  CAS 

留言 (0)

沒有登入
gif